Posts

CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation

Does the doctrine of equivalents apply to novelty?

Biosimilars and generics as "rip-offs": when the facts may not matter

When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued

Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part II)

Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part I)

Novartis fails the priority test - more patents fall

French pharma packaging, IP and generics: can you help?

EU pharma originators v generics: the latest news